Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 1998

View Archived Issues

Amgen: Q4 and FY 1997 highlights

Cel-Sci updates shareholders

Celtrix: Q3 highlights

DiagnoCure: Q4 and FY 1997 highlights

Allergan: FY 1997 highlights

Panretin update

Plant extract DA-9601 protects against NSAID-induced gastric damage

Adenosine agonists with antilipolytic activity described by Glaxo

Icos reveals new cGMP-specific PDE inhibitors

Byk Gulden describes new imidazopyridine PDE IV inhibitors

Celltech reports crosslinked antibodies for cancer indications

Potential new antimigraine agents in development at Allelix

Novel approach to HIV therapy described by ML Laboratories

Zeneca's new antibacterial agents active against resistant pathogens

Inhibitors of secretory PLA2 produced by Streptomyces violaceusniger

Chinese investigators evaluate new MDR-reversing agent

Goralatide: a candidate hematopoietic agent from Beaufour Ipsen

Roche develops orally active anti-HSV agent that targets viral TK

U.S. clearance for naratriptan

CytRx to divest Proceutics subsidiary

Chiroscience and Bristol-Myers Squibb collaborate on MMP inhibitors for cancer

Immunomedics terminates CEA-Scan marketing agreements with Mallinckrodt

Synercid scheduled for FDA committee review next week

Neurocrine Biosciences and Rigel collaborate on gliosis inhibitors

Micrologix, PENCE to collaborate on new antibiotics

Medarex and Schering AG sign antibody agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...